lunes, 26 de febrero de 2018

Fibromialgia / Fibromyalgia

Febrero 26, 2018. No. 3006

Número especial "Terapias con medicamentos para el tratamiento de la fibromialgia"
Special Issue "Drug Therapies for the Treatment of Fibromyalgia"
Biomedicines (ISSN 2227-9059).
Dear Colleagues,
Treatment of fibromyalgia, a common, complex chronic widespread pain condition, is difficult, usually involving an empiric approach to drug therapy focused towards individual symptoms. Current medications are often limited in their effectiveness due to patients discontinuing use as a consequence of a high incidence of adverse effects. Drugs targeting a diverse range of molecular mechanisms have demonstrated modest improvement of health status in patients with fibromyalgia. Thus, the heterogeneity of fibromyalgia, suggesting existence of patient subgroups, central and peripheral aspects of the pathophysiology and a requirement of treatments targeting multiple molecular dysfunction need to be considered in the identification of new or improved therapies for the condition. Authors are invited to submit original or review articles of preclinical and clinical findings contributing to the understanding of drug therapies for the treatment of fibromyalgia.
Dr. Kim Lawson
Guest Editor
Simposio internacional de Emergencias Médicas y Paciente Crítico
Santiago de Chile
31 de Mayo al 1 de Junio, 2018
World Congress on Regional Anesthesia & Pain Medicine
April 19-21, 2018, New York City, USA
Like us on Facebook   Follow us on Twitter   Find us on Google+   View our videos on YouTube 
Anestesiología y Medicina del Dolor

52 664 6848905
Publicar un comentario